The activation of DC Dectin-1 through DC-derived integrin αVβ8 and TGF-β activates these mucosal CD8+ T cells, leading to their retention and accumulation in tumors, which increases cancer cell necrosis and inhibits established breast cancer that grows independently of the tumor microenvironment [25]. Here, CLEC7A is linked to breast carcinoma.